监禁中老年人的认知障碍和痴呆症查:系统性审查
Michael Chike Iloabachie1, Bryce E Stoliker2, Lisa M Jewell2
1School of Public Health, University of Saskatchewan, Saskatoon, SK, Canada.
Dementia (London, England)
|June 26, 2025
概括
本综述强调了认知评估和痴呆症查工具在惩戒机构中对老年人的使用. 早期识别认知障碍可以为必要的支持策略提供信息.
科学领域:
- 老年学是指老年学的学科.
- 法医心理学 法医心理学
- 神经科学是一个神经科学.
背景情况:
- 监狱中的老龄化人口面临着增加的神经认知脆弱性.
- 在惩戒环境中对痴呆症查工具的研究有限.
- 被关押的老年人需要量身定制的认知健康评估.
研究的目的:
- 系统地审查对老年囚犯痴呆症和认知障碍查的经验研究.
- 综合有关监禁环境中查工具的有效性和应用的发现.
主要方法:
- 按照PRISMA指南进行系统审查.
- 搜索了PsycINFO,MedLine,PubMed和学术搜索完整的数据库.
- 包括来自高收入国家的9篇同行评审出版物.
主要成果:
- 确定了在监狱环境中使用的各种认知评估和痴呆症查工具.
- 研究探讨了用于校正环境和创新实践的工具修改.
- 这些发现表明了早期识别认知障碍的潜力.
结论:
- 认知查工具可以帮助早期发现老年囚犯的痴呆症和认知障碍.
- 识别的工具可以为支持和管理策略的实施提供信息.
- 需要进一步的研究来验证对诊断评估的工具性能.
相关概念视频
Cognitive Development During Adulthood
299
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
299
Dementia
174
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
174
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
213
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
213


